New potent calcimimetics: I. Discovery of a series of novel trisubstituted ureas.

Article Details

Citation

Temal T, Jary H, Auberval M, Lively S, Guedin D, Vevert JP, Deprez P

New potent calcimimetics: I. Discovery of a series of novel trisubstituted ureas.

Bioorg Med Chem Lett. 2013 Apr 15;23(8):2451-4. doi: 10.1016/j.bmcl.2013.01.078. Epub 2013 Jan 29.

PubMed ID
23465611 [ View in PubMed
]
Abstract

Starting from Fendiline and R-568, we identified a novel series of urea compounds as positive allosteric modulators of the calcium sensing receptor (CaSR), as part of a program to identify novel therapeutics for secondary hyperparathyroidism. Initially identified disubstituted ureas were converted to trisubstituted urea lead 20e, which was further modified to increase in vivo potency. Replacing a carbomethoxy substituent by various bioisosteres led to compound 46 which exhibited potent in vitro and in vivo activity after oral administration.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
CinacalcetExtracellular calcium-sensing receptorEC 50 (nM)80N/AN/ADetails